Pharvaris
Price & Volume
Stats
See more52W Range | $14.14-$26.99 |
Market Cap | $814M |
Shares Short | 390,943 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.80 |
News
See moreYahoo Finance • 6 days ago
Pharvaris Presents Long-Term Clinical Data of Deucrictibant for the Prevention and Treatment of HAE Attacks at the 2025 AAAAI/WAO Joint Congress
Yahoo Finance • 6 days ago
Pharvaris to Participate in the Leerink Partners Global Healthcare Conference 2025
Yahoo Finance • last year
Pharvaris to Present at the GA²LEN UCARE Conference 2023
Yahoo Finance • last year
Pharvaris Appoints Stefan Abele, Ph.D., as Chief Technical Operations Officer
About
CEO | Mr. Berndt Axel Edvard Modig CPA, M.B.A. |
CFO | Mr. David W. Nassif J.D. |
Address | Emmy Noetherweg 2, Leiden, Netherlands, 2333 BK |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 92 |
